Stephenie Lemon, PhD, is a principal investigator on an $8.75 million grant from the National Institutes of Health National Center for Advancing Translational Sciences to demonstrate the feasibility of community–academic partnerships that will translate into reductions in health disparities for vulnerable patients facing any disease.
The Winter Ball, the premier fundraising gala supporting the mission of the academic health sciences center comprising UMass Medical School and UMass Memorial Medical Center raised more than $1.4 million, a new gala record. More than $500K of that total will support the Neonatal Intensive Care Unit.
A study by Craig J. Ceol, PhD, has revealed that a protein called GDF6, active during early embryo development, plays a primary role in metastatic melanoma. The study was published in the Journal of Clinical Investigation.
UMass Medical School students conducted a survey that found 86 percent of Worcester adults surveyed—including 72 percent of those surveyed who smoke—believe flavored tobacco products should be sold only in adult establishments. They will present their findings at the Worcester Board of Health.
Celia A. Schiffer, PhD, is taking part in a $5.8 million NIH-funded collaboration led by EpiVax, Inc. to develop a protective vaccine against avian flu.
UMass Medical School and Baystate Health officials recently celebrated the opening of the new medical school campus in Springfield and welcomed the first class to the new PURCH track.
Chancellor Michael F. Collins and UMass Medical School employees joined dozens of volunteers at Veterans Inc. in Worcester on Tuesday, Nov. 21, distributing full turkey dinners to hundreds of veterans
The Worcester District Medical Society has honored two UMass Medical School faculty members. Julia Johnson, MD, received the President’s Award and Giles Whalen, MD, accepted the Career Achievement Award.
Jim Glasheen, PhD, a prominent venture capitalist in the biopharmaceutical, medical technology and patient-centered health fields, will join UMass Medical School on Dec. 4 as the executive vice chancellor for innovation & business development.
In this expert’s corner video, David Harlan, MD, explains cutting-edge research at UMass Medical School that allows scientists to better understand how the immune system attacks insulin-producing cells in the pancreas, leading to diabetes.